SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

FERRARESE, Mattia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.500
AS - Asia 1.604
EU - Europa 869
SA - Sud America 239
AF - Africa 27
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.242
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.434
SG - Singapore 627
CN - Cina 462
IT - Italia 238
BR - Brasile 204
DE - Germania 156
HK - Hong Kong 147
VN - Vietnam 101
GB - Regno Unito 77
PL - Polonia 72
ID - Indonesia 63
TR - Turchia 61
UA - Ucraina 59
FI - Finlandia 47
RU - Federazione Russa 45
SE - Svezia 38
CA - Canada 33
MX - Messico 30
FR - Francia 29
JP - Giappone 29
IN - India 22
CZ - Repubblica Ceca 17
AR - Argentina 16
PK - Pakistan 16
BE - Belgio 15
ES - Italia 14
NL - Olanda 14
BD - Bangladesh 12
IR - Iran 12
ZA - Sudafrica 12
NO - Norvegia 10
EC - Ecuador 9
AT - Austria 8
IQ - Iraq 8
KR - Corea 6
LT - Lituania 6
MY - Malesia 6
PT - Portogallo 6
IL - Israele 5
DK - Danimarca 4
GE - Georgia 4
IE - Irlanda 4
KE - Kenya 4
MA - Marocco 4
CL - Cile 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
JO - Giordania 2
LK - Sri Lanka 2
NP - Nepal 2
PY - Paraguay 2
RO - Romania 2
TW - Taiwan 2
AL - Albania 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MK - Macedonia 1
MU - Mauritius 1
OM - Oman 1
PH - Filippine 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
TH - Thailandia 1
TJ - Tagikistan 1
TN - Tunisia 1
UY - Uruguay 1
Totale 5.242
Salva come PNG Salva come JPEG
Città #
Singapore 386
Ashburn 283
Chandler 212
Fairfield 195
Santa Clara 174
Beijing 156
Hong Kong 142
Woodbridge 131
Ferrara 112
Dallas 111
Seattle 90
New York 85
Houston 78
Wilmington 71
Warsaw 69
Cambridge 67
Los Angeles 65
Ann Arbor 64
Munich 57
Jakarta 55
Izmir 46
Jacksonville 43
Princeton 43
Shanghai 42
Nanjing 37
Ho Chi Minh City 36
Dearborn 34
Helsinki 32
Milan 27
São Paulo 25
Bremen 22
Hanoi 21
Tokyo 20
Denver 17
Mexico City 15
Moscow 15
Nanchang 15
Brooklyn 14
Poplar 14
Brno 13
Chicago 13
London 13
Montreal 13
Orem 13
Boardman 12
Falkenstein 12
Guangzhou 12
Redwood City 12
San Diego 12
Toronto 12
Lahore 11
The Dalles 11
Atlanta 10
Brussels 10
Dong Ket 10
Shenyang 10
Bologna 9
Hebei 9
Johannesburg 9
Phoenix 9
Rio de Janeiro 9
Rome 9
Tianjin 9
Jiaxing 8
Frankfurt am Main 7
Oslo 7
Turku 7
Zhengzhou 7
Fairford 6
Kunming 6
Manchester 6
Piemonte 6
San Francisco 6
Stockholm 6
Andover 5
Boston 5
Da Nang 5
Ferrara di Monte Baldo 5
Indore 5
Jinan 5
Nuremberg 5
Ribeirão Preto 5
San Mateo 5
Washington 5
Belo Horizonte 4
Brasília 4
Cagliari 4
Campinas 4
Castagnole delle Lanze 4
Changsha 4
Chennai 4
Columbus 4
Copenhagen 4
Curitiba 4
Des Moines 4
Erlangen 4
Florence 4
Krasnodar 4
Louvain 4
Mumbai 4
Totale 3.569
Salva come PNG Salva come JPEG
Nome #
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency 263
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca 2+ levels and tumor growth 238
Responsiveness of hemophilia B- causing non sense mutations to ribosome readthrough-inducing drugs strictly depends on the nucleotide and prrotein context 207
Transposon-mediated Generation of Cellular and Mouse Models of Splicing Mutations to Assess the Efficacy of snRNA-based Therapeutics 194
An Altered Splicing Registry Explains the Differential ExSpeU1-Mediated Rescue of Splicing Mutations Causing Haemophilia A 190
Specific factor IX mRNA and protein features favor drug-induced readthrough over recurrent nonsense mutations 181
The chaperone-like sodium phenylbutyrate improves factor IX intracellular trafficking and activity impaired by the frequent p.R294Q mutation 176
Missense changes in the catalytic domain of coagulation factor X account for minimal function preventing a perinatal lethal condition 170
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 153
Secretion of wild-type factor IX upon readthrough over F9 pre-peptide nonsense mutations causing hemophilia B 152
A strategy with chaperone-like compounds to restore expression of factor IX variants affected by frequent missense mutations causing hemophilia B 151
The carboxyl-terminal region of human coagulation factor X as a natural linker for fusion strategies 142
The carboxyl-terminal region of human coagulation factor X as a novel naturally-occuring linker for fusion strategies 139
An engineered human albumin enhances half-life and transmucosal delivery when fused to protein-based biologics 137
An exon-specific small nuclear u1 rna (Exspeu1) improves hepatic otc expression in a splicing-defective spf /ash mouse model of ornithine transcarbamylase deficiency 135
Protein engineering and pharmacological approaches to develop novel treatment strategies for coagulation disorders 135
A Compensatory U1snRNA Partially Rescues FAH Splicing and Protein Expression in a Splicing-Defective Mouse Model of Tyrosinemia Type I 132
A next-generation rFVIIa fusion protein with enhanced half-life as a novel by-passing tool in hemophilia 131
An optimized in vitro expression platform identifies Haemophilia B nonsense mutations, and thus patients, eligible for therapeutic drug-induced readthrough 130
Mutation-specific contributions to trace factor X levels account for a life-threating phenotype in a compound heterozygous factor X deficient patient 130
Fusion of engineered albumin with factor IX Padua extends half-life and improves coagulant activity 130
Exploring chaperone-like compounds as innovative therapeutic correction approach for factor IX missense mutations causing type I Haemophilia B 129
The chaperone-like compound sodium phenylbutyrate improves intracellular trafficking, secretion and coagulant activity of factor IX impaired by the frequent p.R294Q mutation 128
Design of a novel factor IX albumin fusion protein with enhanced coagulant activity and pharmacokinetic profile 127
Rational engineering of a novel factor IX albumin fusion protein results in enhanced coagulant activity and pharmacokinetic profile 126
Detection of Residual Factor VIII Levels Reveals the Occurrence of Readthrough Over the Majority of F8 Nonsense Mutations 119
Readthrough-mediated functional suppression of homozygous nonsense mutations accounts for variable bleeding phenotypes in factor VII deficiency 115
Translational readthrough of GLA nonsense mutations suggests dominant-negative effects exerted by the interaction of wild-type and missense variants 115
Identification of novel mechanisms underlying functional response to drug-induced readthrough of haemophilia B nonsense mutations 115
Design of a novel factor IX variant with enhanced procoagulant activity and half-life 112
Exploring chaperone-like compounds as innovative therapeutic strategy for Hemophilia B 106
An advanced method for the small-scale production of high-quality minicircle DNA 105
Comparative Analysis Of Residual Factor VIII Expression from Recurrent F8 Nonsense Mutations Indicates that Localization in the B- domain Favours Readthrough- mediated Protein Output 102
Next generation factor VIIa with enhanced half-life 96
Spontaneous readthrough over recurrent F8 nonsense mutations is associated with residual factor VIII levels: implications for inhibitor risk? 94
null 93
Recombinant Expression of F9 Nonsense Mutations and Fix Pharmacokinetics in Hemophilia B 85
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains 73
Translational readthrough at F8 nonsense variants in the factor VIII B domain contributes to residual expression and lowers inhibitor association 70
Suppression of “leaky” nonsense mutations by ribosome readthrough accounts for residual factor IX levels in Haemophilia B patients 65
Totale 5.391
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.798
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.798
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021339 0 0 0 0 0 38 58 60 25 66 51 41
2021/2022358 59 35 8 4 21 22 5 12 17 31 21 123
2022/2023436 48 61 12 62 62 50 30 31 42 5 18 15
2023/2024285 10 23 16 4 17 61 15 30 6 9 12 82
2024/20251.124 36 20 97 29 130 167 20 23 178 103 181 140
2025/20261.731 299 181 229 415 460 147 0 0 0 0 0 0
Totale 5.391